Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):311–318. doi: 10.1097/QAI.0000000000002032

Figure 1.

Figure 1.

Adjusted area under the receiver operating characteristics (ROC) curves of DBS TFV-DP (grey), plasma EFV (green), plasma TFV (maroon), and self-reported adherence (blue) to predict viral suppression; n=137 (adjusted for age and duration on ART)